# Libende Pegylated Liposomal Doxorubicin

*Pegylated Liposomal Doxorubicin*

Libende is a pegylated liposomal doxorubicin formulation presented as an intravenous injectable dispersion. It is indicated for the treatment of various malignancies, including metastatic ovarian cancer, AIDS-related Kaposi sarcoma, metastatic breast cancer, and multiple myeloma.

## Overview

- **Manufacturer:** AMEGA Biotech
- **Product type:** Agentes de quimioterapia citotóxica
- **Specialties:** Oncología
- **Usage classification:** Single-Use

## Key features

- Pegylated liposomal formulation
- Intravenous injectable dispersion
- Indicated for patients with increased cardiac risk in breast cancer therapy

## Highlights & advantages

### Clinical Indication

- Metastatic ovarian carcinoma (refractory to paclitaxel and platinum-based regimens)
- AIDS-related Kaposi sarcoma (with low CD4 counts and extensive disease)
- Metastatic breast carcinoma (where anthracycline monotherapy is indicated)
- Multiple myeloma (in combination with Bortezomib)

## Specifications

| Specification | Value |
| --- | --- |
| Concentration | 20 mg/10ml |

## Variants

- **Libende 20mg/10ml** (Volume (ml): 10; Concentration (mg/ml): 2): Standard 10ml vial containing 20mg of pegylated liposomal doxorubicin.

## Frequently asked questions

### What is the primary delivery method for Libende?

Libende is administered as an intravenous liposomal dispersion.

### Is Libende suitable for patients with cardiac concerns?

Yes, it is indicated for patients with metastatic breast carcinoma for whom anthracycline monotherapy is indicated, including those with an increased cardiac risk.

### What are the specific requirements for Kaposi sarcoma patients?

Patients must have disease progression, CD4 counts below 200 cells/mm³, and have received prior combination chemotherapy or be intolerant to such therapy.

## Documents

- [Libende Pegylated Liposomal Doxorubicin IFU](https://api.dev.mytradeloop.com/storage/4325~lO1Xu-gkCvbTslc2) (ifu, es, 2p)

## Browse placement

- Atención secundaria › Oncología
- Productos farmacéuticos y biológicos › Fármacos oncológicos

## Tags

liposomal-dispersion, intravenous-injectable, pegylated liposomal doxorubicin, doxorubicin injection, oncology chemotherapy, metastatic ovarian cancer treatment, aids related kaposi sarcoma, metastatic breast cancer, multiple myeloma treatment

> Made by [AMEGA Biotech](https://dev.mytradeloop.com/es/companies/amega-biotech-9638). Contact the manufacturer via their profile page.

---

*Source: [mytradeloop](https://dev.mytradeloop.com/es/products/libende-pegylated-liposomal-doxorubicin-89535). This is the machine-readable (markdown) representation of the page at https://dev.mytradeloop.com/es/products/libende-pegylated-liposomal-doxorubicin-89535.*